Biotricity

Biotricity EBIT per Employee

Delisted

The EBIT per Employee of Biotricity (BTCY) as of Oct 27, 2026 is -13,077.78 USD. In the previous year, EBIT per Employee was -322,750.00 USD — a change of -95.95% (higher).

EBIT per Employee

-13,077.78USD

YoY

-95.95%

Last updated:

EBIT per Employee of Biotricity is 2025 -13,077.78 USD. EBIT per Employee of Biotricity was 2024 -322,750.00 USD. It decreases by -95.95% higher compared to the previous year.

The Biotricity EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
-428,888.89 USD
Jan 1, 2019
-476,666.67 USD
Jan 1, 2020
-607,222.22 USD
Jan 1, 2021
-715,000.00 USD
Jan 1, 2022
-970,555.56 USD
Jan 1, 2023
-756,666.67 USD
Jan 1, 2024
-322,750.00 USD
Jan 1, 2025
-13,077.78 USD
The Biotricity EBIT per Employee history
YEAREBIT per EmployeeYoY
-13,077.78USD-95.95%
-322,750.00USD-57.35%
-756,666.67USD-22.04%
-970,555.56USD+35.74%
-715,000.00USD+17.75%
-607,222.22USD+27.39%
-476,666.67USD+11.14%
-428,888.89USD+29.97%
-330,000.00USD+19.52%
-276,111.11USD-3.12%
-285,000.00USD+200.00%
-95,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotricity Stock analysis

What does Biotricity do? Biotricity, Inc. generates revenue through its remote biometric monitoring solutions, primarily targeting healthcare providers and patients with chronic conditions. The company offers bioflux, an Electrocardiogram (ECG) monitoring system that enables physicians to diagnose cardiovascular diseases and coronary heart diseases, detect arrhythmias via ambulatory monitoring, and provide real-time remote mobile cardiac telemetry diagnostics. Additionally, Biotricity sells biolife, a health and lifestyle solution for individuals that monitors heart-rhythm, ECG, respiration, calories, temperature, and physical activity through a dedicated device. Healthcare institutions and patients seeking chronic condition management and lifestyle improvement are the primary buyers of these products. The firm's revenue streams are derived from the sale of bioflux systems to medical professionals for diagnostic and post-diagnostic use, while biolife targets individual consumers for personal health monitoring. Bioflux is utilized by physicians for real-time ECG data transmission and arrhythmia detection, and biolife is marketed directly to individuals for comprehensive health tracking. Both products are sold through direct sales channels to their respective target segments. Biotricity's business model relies on the dual focus of medical diagnostics and consumer health solutions. The company's products are designed to serve two distinct market segments: healthcare providers using bioflux for clinical diagnostics and patients using biolife for personal health management. The remote monitoring capabilities of both systems facilitate ongoing health data collection and analysis, supporting chronic disease management and lifestyle enhancement. Biotricity is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotricity stock

EBIT per Employee of Biotricity is -13,077.78 USD in 2025.

EBIT per Employee of Biotricity changed from -322,750.00 USD to -13,077.78 USD, representing a -95.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Biotricity since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Biotricity historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Biotricity

All Key Metrics — Biotricity